The global COVID-19 vaccine-addressable market before the spread of COVID-19 was valued at 47 billion in 2019 and was expected to reach USD 86.4 billion by 2027, at a CAGR of 7%. With the outbreak of novel coronavirus in December 2019, the market has tremendous potential.
Coronaviruses belong to Torovirinae subfamily. ‘Corona’ is a Latin word meaning crown, that is, corona virus particles have crown-like appearance. These viruses are known to cause infections in mammals and birds. Human coronaviruses were first discovered in 1960. The 2019 novel corona virus disease (COVID-19) is a highly infectious disease spread through droplets of saliva or discharge from nose of an infected person. It was first found in Wuhan, China. The symptoms of COVID-19 include difficulty in breathing, cough, fever, and sore throat. It can infect people of all ages. However, people suffering on diabetes, heart and respiratory diseases, and the geriatric population is more susceptible to it. Currently, no vaccine has been developed for fighting the virus. The only option available with people is to take precautionary measures to avoid catching the virus, such as, wash hands frequently or rub with alcohol-based sanitiser, avoid touching your mouth and nose, and maintain social-distancing.
The global COVID-19 vaccine-addressable market is expected to grow tremendously with an exponential rise in the number of infected people across the globe. As per the WHO Situation Report of 9th May 2020, the total cases of COVID-19 are 3.85 million with 265,862 deaths globally. With several companies and institutions across the globe doing trials for the development of vaccine, the market has huge potential. The use of therapies which were earlier used for treating other epidemics like MERS, SARS, and H1N1, such as convalescent plasma therapy will boost the market growth. The collaborations among governments and organisations of various nations for the supply for medical equipment and essential drugs is expected to contribute to market growth.
The COVID-19 vaccine-addressable market has been segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America is expected to dominate the market due to presence of big players and massive investments by the companies, government, and various institutions in the research and development to come up with the COVID-19 vaccine as soon as possible. Also, as of 9th March 2020, the US has the highest number of cases amounting to 1.24 million with 30,303 deaths.
Presently, there are 115 COVID-19 vaccine candidates. The candidates who have achieved highest clinical development include Ad5-nCoV from CanSino Biologics, mRNA-1273 from Moderna, LV-SMENP-DC from Shenzhen Geno-Immune Medical Institute, and INO-4800 from Inovio.
The leading players of the market include Johnson & Johnson Services, Inc, Pfizer Inc., GlaxoSmithKline plc., Serum Institute of India, Merck and Co., Sanofi, Moderna Inc., Inovio Pharmaceuticals, Inc, and BioNTech SE. In April 2020, an announcement was made by the Bill and Melinda Gates Foundation for funding companies that have potential promising vaccines.
Global COVID-19 Vaccine-Addressable Market Analysis And Forecast, By Regional Analysis
Report Description:
The market estimates have been evaluated by considering the effect of different political, economic, social, technological and legal factors which are based on our extensive secondary research, primary research, and in-house databases.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. Increasing number of covid-19 cases
5.2.2. Growing use of former therapies
5.3. Restraints
5.3.1. Ill-effects of the vaccine
5.4. Opportunities
5.4.1. Increasing healthcare expenditure
5.4.2. Collaboration among governments and various organizations
5.5. Challenges
5.5.1. Limited number of efficient manufacturers
6. Global COVID-19 Vaccine-Addressable Market Analysis and Forecast, By Regional Analysis
6.1. Segment Overview
6.2. North America
6.2.1. U.S.
6.2.2. Canada
6.2.3. Mexico
6.3. Europe
6.3.1. Germany
6.3.2. France
6.3.3. U.K.
6.3.4. Italy
6.3.5. Spain
6.4. Asia-Pacific
6.4.1. Japan
6.4.2. China
6.4.3. India
6.5. South America
6.5.1. Brazil
6.6. Middle East and Africa
6.6.1. UAE
6.6.2. South Africa
7. Global COVID-19 Vaccine-Addressable Market-Competitive Landscape
7.1. Overview
7.2. Market Share of Key Players in Global COVID-19 Vaccine-Addressable Market
7.2.1. Global Company Market Share
7.2.2. North America Company Market Share
7.2.3. Europe Company Market Share
7.2.4. APAC Company Market Share
7.3. Competitive Situations and Trends
7.3.1. Product Launches and Developments
7.3.2. Partnerships, Collaborations and Agreements
7.3.3. Mergers & Acquisitions
7.3.4. Expansions
8. Company Profiles
8.1. Johnson & Johnson Services Inc.
8.1.1. Business Overview
8.1.2. Company Snapshot
8.1.3. Company Market Share Analysis
8.1.4. Company Product Portfolio
8.1.5. Recent Developments
8.1.6. SWOT Analysis
8.2. Pfizer Inc.
8.2.1. Business Overview
8.2.2. Company Snapshot
8.2.3. Company Market Share Analysis
8.2.4. Company Product Portfolio
8.2.5. Recent Developments
8.2.6. SWOT Analysis
8.3. GlaxoSmithKline plc.
8.3.1. Business Overview
8.3.2. Company Snapshot
8.3.3. Company Market Share Analysis
8.3.4. Company Product Portfolio
8.3.5. Recent Developments
8.3.6. SWOT Analysis
8.4. Serum Institute of India
8.4.1. Business Overview
8.4.2. Company Snapshot
8.4.3. Company Market Share Analysis
8.4.4. Company Product Portfolio
8.4.5. Recent Developments
8.4.6. SWOT Analysis
8.5. Merck and Co.
8.5.1. Business Overview
8.5.2. Company Snapshot
8.5.3. Company Market Share Analysis
8.5.4. Company Product Portfolio
8.5.5. Recent Developments
8.5.6. SWOT Analysis
8.6. Sanofi, Moderna Inc.
8.6.1. Business Overview
8.6.2. Company Snapshot
8.6.3. Company Market Share Analysis
8.6.4. Company Product Portfolio
8.6.5. Recent Developments
8.6.6. SWOT Analysis
8.7. Inovio Pharmaceuticals Inc.
8.7.1. Business Overview
8.7.2. Company Snapshot
8.7.3. Company Market Share Analysis
8.7.4. Company Product Portfolio
8.7.5. Recent Developments
8.7.6. SWOT Analysis
8.8. BioNTech SE
8.8.1. Business Overview
8.8.2. Company Snapshot
8.8.3. Company Market Share Analysis
8.8.4. Company Product Portfolio
8.8.5. Recent Developments
8.8.6. SWOT Analysis
8.9. A2A
8.9.1. Business Overview
8.9.2. Company Snapshot
8.9.3. Company Market Share Analysis
8.9.4. Company Product Portfolio
8.9.5. Recent Developments
8.9.6. SWOT Analysis
8.10. Bharat Biotech
8.10.1. Business Overview
8.10.2. Company Snapshot
8.10.3. Company Market Share Analysis
8.10.4. Company Product Portfolio
8.10.5. Recent Developments
8.10.6. SWOT Analysis
8.11. AbbVie
8.11.1. Business Overview
8.11.2. Company Snapshot
8.11.3. Company Market Share Analysis
8.11.4. Company Product Portfolio
8.11.5. Recent Developments
8.11.6. SWOT Analysis
8.12. Celularity
8.12.1. Business Overview
8.12.2. Company Snapshot
8.12.3. Company Market Share Analysis
8.12.4. Company Product Portfolio
8.12.5. Recent Developments
8.12.6. SWOT Analysis
8.13. Epivax
8.13.1. Business Overview
8.13.2. Company Snapshot
8.13.3. Company Market Share Analysis
8.13.4. Company Product Portfolio
8.13.5. Recent Developments
8.13.6. SWOT Analysis
8.14. Flugen
8.14.1. Business Overview
8.14.2. Company Snapshot
8.14.3. Company Market Share Analysis
8.14.4. Company Product Portfolio
8.14.5. Recent Developments
8.14.6. SWOT Analysis
8.15. iBio
8.15.1. Business Overview
8.15.2. Company Snapshot
8.15.3. Company Market Share Analysis
8.15.4. Company Product Portfolio
8.15.5. Recent Developments
8.15.6. SWOT Analysis
List of Table
1. North America COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
2. U.S. COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
3. Canada COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
4. Mexico COVID-19 Vaccine-Addressable Market, By 2019-2027 (USD Billion)
5. Europe COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
6. Germany COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
7. France COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
8. U.K. COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
9. Italy COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
10. Spain COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
11. Asia Pacific COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
12. Japan COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
13. China COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
14. India COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
15. South America COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
16. Brazil COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
17. Middle East and Africa COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Billion)
18. UAE COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Million)
19. South Africa COVID-19 Vaccine-Addressable Market, 2019-2027 (USD Million)
List of Figures
1. Global COVID-19 Vaccine-Addressable Market Segmentation
2. Global COVID-19 Vaccine-Addressable Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global COVID-19 Vaccine-Addressable Market Attractiveness Analysis By Region
9. Global COVID-19 Vaccine-Addressable Market: Dynamics
10. Global COVID-19 Vaccine-Addressable Market Share by Regions (2020 & 2027)
11. Global COVID-19 Vaccine-Addressable Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.